Home
News
Create
Screeners
Insights
Bal Pharma
81.
86
+1.50
(+1.87%)
Market Cap
₹130.30 Cr
PE Ratio
18.16
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+1.87%
1M
-1.28%
6M
-14.65%
1Y
-34.91%
5Y
+38.75%
View Company Insights
Latest news about Bal Pharma
Bal Pharma Defers Subsidiary Merger Decision, Citing Need for More Data
1 day ago
Bal Pharma Limited has postponed its decision on the proposed merger of its subsidiary, Lifezen Healthcare Pvt Ltd, with the parent company. The Board of Directors found the available data inadequate for making an informed decision during their recent meeting. The management has been instructed to re-present the proposal with all necessary details. The board meeting was held on 11.08.2025, and the company provided clarification to the stock exchange on 06.11.2025 regarding the deferred decision.
Bal Pharma Reports Q1 FY2026 Results, Approves Employee Stock Option Plan
Aug 11, 2025
Bal Pharma Schedules Board Meeting to Discuss Q1 Results, ESOP, and Subsidiary Merger
Jul 29, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation